-
Study aim
-
Determination of the effectiveness of potassium citrate solution in the treatment of renal microlithiasis in children one month to 15 years old
-
Design
-
A phase 3 clinical trial with one intervention group and one control group as parallel groups, simple randomized by coded card selection, and a sample size of 60
-
Settings and conduct
-
In this study, 60 children between the ages of 1 month and 15 years referred to Hajar Hospital in Shahrekord who have microlithiasis less than 3 mm in sonography will randomly be divided into 2 groups by selecting a card. In the first group of children, only conservative and protective measures such as breast milk consumption, prevention of dehydration and less salt consumption will be recommended, and in the second group, in addition to supportive measures, they will be treated with potassium citrate solution for 3 months. Then, to evaluate the presence or absence, size and number of stones, patients in both groups will be examined and compared with sonography after 3 months.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: children aged 1 month to 15 years with kidney stones less than 3 mm and parental consent to participate in the study; Exclusion criteria: renal hydronephrosis, multiple stones, urinary reflux, recurrent urinary tract infection
-
Intervention groups
-
In one group of children, only conservative and supportive measures such as breastfeeding, dehydration prevention and less salt intake will be recommended, and in the other group, in addition to supportive measures, they will be treated with potassium citrate solution (Combination of 22% potassium citrate powder and 68.8% acetic acid from Merck factory in Germany with distilled water) for 3 months.
-
Main outcome variables
-
Number of stones; Size of stones